C4U Corporation
- Biotech or pharma, therapeutic R&D
Our gene editing technology, CRISPR-Cas3 has significant features, such as:
High specificity, wide deletion and no off-target. In addition, we could provide FTO in terms of patent protection world wide.
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}